Dr Brian N Brodish, MD | |
850 Johns Hopkins Dr, Greenville, NC 27834-7222 | |
(252) 752-5227 | |
(252) 752-1191 |
Full Name | Dr Brian N Brodish |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 30 Years |
Location | 850 Johns Hopkins Dr, Greenville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104879691 | NPI | - | NPPES |
126N7 | Other | NC | BCBS |
89126N7 | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vidant Medical Center | Greenville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Eastern Carolina Ear, Nose And Throat-head And Neck Surgery, Inc | 1850485020 | 13 |
News Archive
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.
American Medical News: Through teleconferencing technology, doctors are able to treat patients who live far away without access to a specialist. "Nationwide, telemedicine increasingly is being used to bridge gaps in access to care in rural and other medically underserved communities that have a hard time recruiting physicians.
Epilepsy and depression are common co-morbidities. Concern for the potential of certain antidepressants to induce seizures has led to under-treating depression and anxiety disorders in epilepsy patients. Research presented today at the 66th American Epilepsy Society meeting suggests that antidepressants in normal dosage may have a positive impact on both mood and seizure frequency.
› Verified 4 days ago
Entity Name | Vidant Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477648731 PECOS PAC ID: 0345343893 Enrollment ID: O20070321000445 |
News Archive
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.
American Medical News: Through teleconferencing technology, doctors are able to treat patients who live far away without access to a specialist. "Nationwide, telemedicine increasingly is being used to bridge gaps in access to care in rural and other medically underserved communities that have a hard time recruiting physicians.
Epilepsy and depression are common co-morbidities. Concern for the potential of certain antidepressants to induce seizures has led to under-treating depression and anxiety disorders in epilepsy patients. Research presented today at the 66th American Epilepsy Society meeting suggests that antidepressants in normal dosage may have a positive impact on both mood and seizure frequency.
› Verified 4 days ago
Entity Name | Eastern Carolina Ear, Nose & Throat-head & Neck Surgery, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912957606 PECOS PAC ID: 1850485020 Enrollment ID: O20070919000226 |
News Archive
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.
American Medical News: Through teleconferencing technology, doctors are able to treat patients who live far away without access to a specialist. "Nationwide, telemedicine increasingly is being used to bridge gaps in access to care in rural and other medically underserved communities that have a hard time recruiting physicians.
Epilepsy and depression are common co-morbidities. Concern for the potential of certain antidepressants to induce seizures has led to under-treating depression and anxiety disorders in epilepsy patients. Research presented today at the 66th American Epilepsy Society meeting suggests that antidepressants in normal dosage may have a positive impact on both mood and seizure frequency.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Brian N Brodish, MD 850 Johns Hopkins Dr, Greenville, NC 27834-7222 Ph: (252) 752-5227 | Dr Brian N Brodish, MD 850 Johns Hopkins Dr, Greenville, NC 27834-7222 Ph: (252) 752-5227 |
News Archive
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.
American Medical News: Through teleconferencing technology, doctors are able to treat patients who live far away without access to a specialist. "Nationwide, telemedicine increasingly is being used to bridge gaps in access to care in rural and other medically underserved communities that have a hard time recruiting physicians.
Epilepsy and depression are common co-morbidities. Concern for the potential of certain antidepressants to induce seizures has led to under-treating depression and anxiety disorders in epilepsy patients. Research presented today at the 66th American Epilepsy Society meeting suggests that antidepressants in normal dosage may have a positive impact on both mood and seizure frequency.
› Verified 4 days ago
Dr. Eric O Lindbeck, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 850 Johns Hopkins Dr, Greenville, NC 27834 Phone: 252-752-5227 Fax: 252-752-1191 | |
Dr. Jonathan R Workman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 850 Johns Hopkins Dr, Greenville, NC 27834 Phone: 252-752-5227 Fax: 252-752-1191 | |
Dr. Paul B Brechtelsbauer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 850 Johns Hopkins Dr, Greenville, NC 27834 Phone: 252-752-5227 Fax: 252-752-1191 | |
Dr. Jamie S Grubey, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 850 Johns Hopkins Dr, Greenville, NC 27834 Phone: 252-752-5227 Fax: 252-752-1191 | |
Dr. Marcus S Albernaz, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 850 Johns Hopkins Dr, Greenville, NC 27834 Phone: 252-752-5227 Fax: 252-752-1191 |